Global Biotechnology

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

The global biotechnology industry had total revenues of $323.1bn in 2014, representing a compound annual growth rate (CAGR) of 7.2% between 2010 and 2014.

The medical/healthcare segment was the industry's most lucrative in 2012, with total revenues of $182.5bn, equivalent to 60.0% of the industry's overall value.

The performance of the industry is forecast to decelerate, with an anticipated CAGR of 5.7% for the five-year period 2014 – 2019, which is expected to drive the industry to a value of $427.3bn by the end of 2019.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in the global

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons to buy

What was the size of the Global biotechnology market by value in 2014?

What will be the size of the Global biotechnology market in 2019?

What factors are affecting the strength of competition in the Global biotechnology market?

How has the market performed over the last five years?

Companies mentioned

Amgen, Inc., Covance Inc., Merck & Co., Inc. and F. Hoffmann-La Roche Ltd

Table of Contents

TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Category segmentation 9

Geography segmentation 10

Market Outlook 11

Market value forecast 11

Five Forces Analysis 12

Summary 12

Buyer power 13

Supplier power 14

New entrants 15

Threat of substitutes 17

Degree of rivalry 18

Leading Companies 19

Amgen, Inc. 19

Covance Inc. 22

Merck & Co., Inc. 25

F. Hoffmann-La Roche Ltd 28

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33

LIST OF TABLES

Table 1: Global biotechnology industry value: $ billion, 201014(e) 8

Table 2: Global biotechnology industry category segmentation: $ billion, 2014(e) 9

Table 3: Global biotechnology industry geography segmentation: $ billion, 2014(e) 10

Table 4: Global biotechnology industry value forecast: $ billion, 201419 11

Table 5: Amgen, Inc.: key facts 19

Table 6: Amgen, Inc.: key financials ($) 20

Table 7: Amgen, Inc.: key financial ratios 20

Table 8: Covance Inc.: key facts 22

Table 9: Covance Inc.: key financials ($) 23

Table 10: Covance Inc.: key financial ratios 23

Table 11: Merck & Co., Inc.: key facts 25

Table 12: Merck & Co., Inc.: key financials ($) 26

Table 13: Merck & Co., Inc.: key financial ratios 26

Table 14: F. Hoffmann-La Roche Ltd: key facts 28

Table 15: F. Hoffmann-La Roche Ltd: key financials ($) 29

Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF) 29

Table 17: F. Hoffmann-La Roche Ltd: key financial ratios 29

LIST OF FIGURES

Figure 1: Global biotechnology industry value: $ billion, 201014(e) 8

Figure 2: Global biotechnology industry category segmentation: % share, by value, 2014(e) 9

Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2014(e) 10

Figure 4: Global biotechnology industry value forecast: $ billion, 201419 11

Figure 5: Forces driving competition in the global biotechnology industry, 2014 12

Figure 6: Drivers of buyer power in the global biotechnology industry, 2014 13

Figure 7: Drivers of supplier power in the global biotechnology industry, 2014 14

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2014 15

Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2014 17

Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2014 18

Figure 11: Amgen, Inc.: revenues & profitability 21

Figure 12: Amgen, Inc.: assets & liabilities 21

Figure 13: Covance Inc.: revenues & profitability 23

Figure 14: Covance Inc.: assets & liabilities 24

Figure 15: Merck & Co., Inc.: revenues & profitability 26

Figure 16: Merck & Co., Inc.: assets & liabilities 27

Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability 30

Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities 30

List of Tables

NA

List of Figures

NA

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports